Dicot's business concept is to develop the product Libiguin® as a drug for treating sexual dysfunctions. The development takes place on its own up to clinical phases.
Press release
23 November, 2020
Summary of Interim Report January - September 2020, Dicot AB
Press release: Uppsala, November 23, 2020. A summary of the Interim report January - September 2020, for Dicot AB (publ) is now avalible on the company webbsite www.dicot.se .
Press release
18 November, 2020
Significant progress in the production of Dicot's drug candidate
Press release: Uppsala, November 18, 2020. Dicot has produced its second large-scale batch of the drug substance for Libiguin®. The production has improved significantly, which means that 2.5 times as much drug substance has been produced from the sa...
Watch CEO Göran Beijer presenting the company:
Contact us
Dicot AB
Dag Hammarskjölds Väg 30
SE-752 37 Uppsala SWEDEN
+46 (0) 70-663 60 09
info@dicot.se
The information is processed according to our privacy policy.